Loading…
Underlying
Underlying Price
$8.33
Type
Put
Strike
1.5
Expiration
Jan 21, 2028
DTE
458d
Moneyness
OTM
Intrinsic
$0.00
IBRX 1.5 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Jan 15, 2027 | 87d | $0.19 | +90.00% | 6 | 299 |
| Jan 21, 2028 | 458d | $0.10 | -23.08% | 30 | 126 |
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.